KI Innovations AB

What KI Innovations AB does

KI Innovations AB (commercial name "KI Innovation") is a Swedish life science innovation and incubation company headquartered in Solna, Sweden, operating as the commercial interface of Karolinska Institutet (KI). The entity runs four integrated programs — Innovation Lab (early-stage ideation support), KI Incubator (venture creation), KI Science Park (a community and facilities offering for resident startups), and Access to Capital (structured funding facilitation) — designed to translate research from KI and its partner hospitals into investable companies. Its core customers are KI researchers, clinicians at Karolinska University Hospital and Astrid Lindgren Children's Hospital, and the resulting portfolio of early-stage life science startups.

The portfolio spans digital health (AstmaTuner, HeartRunner), AI-enabled radiology (Collective Minds Radiology, connecting 8,000+ radiologists), AI-driven oncology diagnostics (Stratipath), and biotech (HAGA.BIO, Serendo Therapeutics). HAGA.BIO has raised SEK 20.9M, providing a public data point on portfolio capitalization activity, though no company-level revenue, headcount, or funding figure is disclosed for KI Innovations AB itself. In April 2026, the company rebranded from "Karolinska Institutet Innovation" to "KI Innovation," consolidating its four programs under a unified brand.

Revenue mechanics are not explicitly disclosed but appear to combine: (1) membership and facility fees from KI Science Park tenants, (2) program/service fees from startups in the Innovation Lab and KI Incubator, (3) co-investment economics through the Access to Capital program, and (4) partner-funded programs such as the AbbVie Scandinavia Golden Ticket. The business model is therefore closer to a hybrid incubator/venture-builder than a SaaS or product company, with revenue tied to portfolio throughput and partnership economics rather than a per-seat enterprise contract.

Name

KI Innovations AB

Legal name

KI Innovations AB

Website

https://karolinskainnovations.ki.se

Company type

Private

Founded year

1810

Operating status

Operating

Short description

KI Innovations AB is a Swedish life science incubator and venture builder linked to Karolinska Institutet, running Innovation Lab, KI Incubator, KI Science Park, and Access to Capital programs that help KI researchers and clinicians commercialize research into portfolio companies across digital health, AI, and biotech.

Ownership category

akta.pro rank

Product category

Life Science Innovation Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Technical Universities with Entrepreneurship & Incubation Focus (EDAHAEAH)

akta.pro secondary industry

Applied Research & Innovation Universities (EDAHAEAE)

Keywords

• Life science innovation
• Startup incubation
• Research commercialization
• Healthcare ventures
• Medical innovation ecosystem

Headquarters

HQ city

Solna

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Membership Programs: KI Science Park membership providing access to community, networking events, and ecosystem benefits for life science companies and researchers.
2. Incubator Services: Business development and coaching services for startups within the KI Incubator program, supporting companies ready to scale internationally.
3. Innovation Lab Services: Feasibility assessment and idea validation support for researchers exploring commercial potential of their discoveries.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

KI Innovations AB operates a life science innovation ecosystem that helps transform research from Karolinska Institutet into commercial products and services. It delivers four core programs: Innovation Lab (feasibility assessment and idea validation for academic researchers), KI Incubator (business development, coaching, and resources for startups ready to scale internationally), KI Science Park (membership community connecting startups, industry, and academia), and Access to Capital (co-investment and investor-introduction programs).

Product overview

KI Innovation operates as a unified life science innovation ecosystem with three interconnected service programs—Innovation Lab (for researchers exploring idea feasibility), KI Incubator (for startups scaling internationally), and KI Science Park (a community platform connecting startups, industry, and academia). An Access to Capital program provides co-investment pathways. The organization connects people, science, and capital across the full innovation journey from early research to global companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Innovation Lab
• KI Incubator
• KI Science Park
• Access to Capital

Quantifiable outcome

• 8,000+ radiologists connected globally through Collective Minds Radiology platform
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Astrid Lindgren Children's HospitalcoreStrategic or Co-development PartnerClinical partner where innovations such as the AstmaTuner wireless lung function meter originated. Provides clinical validation environment and researcher access for the KI Innovation ecosystem.
• Karolinska University HospitalcoreStrategic or Co-development PartnerPrimary clinical partner providing access to clinical environments, pathologists (e.g., for Stratipath), and healthcare professionals for innovation validation and collaboration. Hosts researchers from both the hospital and Karolinska Institutet.
• Karolinska Institutet (KI)coreStrategic or Co-development PartnerParent academic institution providing the research base, talent pool, and institutional framework for KI Innovation. The organization's innovation and entrepreneurship ecosystem is rooted in KI's world-leading medical research.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• JLABS (Johnson & Johnson Innovation): Global network of life science incubators backed by Johnson & Johnson, offering residency, mentorship, and capital access to healthcare startups — comparable as a pharma-anchored life science incubator with global footprint and capital programs.
• MIT Technology Licensing Office: Manages technology transfer, licensing, and startup formation from MIT research across biotech, medtech, and engineering — comparable as a leading research university commercialization office.
• Stanford Office of Technology Licensing: Handles invention disclosure, licensing, and startup support from Stanford research, with significant life science activity — comparable as a top-tier global research university commercialization office.

Others

• Sciety: Nordic private investor platform syndicating investment rounds in life science startups, often emerging from academic research — comparable as a Nordic ecosystem participant supporting the same startup capital pathway that KI Innovation's Access to Capital program addresses.

Direct peers

• LabCentral: U.S.-based life science incubator providing lab space, programming, and networking for biotech startups — comparable as a life science-focused incubator offering community, business support, and capital connections to early-stage companies.
• Oxford University Innovation: The technology transfer and startup incubation office of the University of Oxford, providing consulting, incubation, and seed funding for academic spinouts across life sciences, medtech, and digital health — a closely analogous mission.
• Cambridge Enterprise: University-linked commercialization arm of the University of Cambridge that licenses technology, supports startups, and manages investment activities — directly comparable as an academic innovation and incubation entity serving life sciences and deep tech.
• BioInnovation Institute (BII): Danish-based life science incubator and venture builder supporting startups from ideation through Series A, with strong ties to Nordic academic research and pharma partners — directly comparable as a Nordic life science incubator with co-investment programs.
• Imperial College Innovations (Imperial College London's tech transfer office): Handles commercialization, incubator support, and spinout creation from Imperial College London, with a strong focus on life sciences, medtech, and engineering research — comparable as a research-intensive European university commercialization arm.

Regional players

• STUNS Life Science: Swedish life science business incubator network supporting early-stage life science companies in Uppsala and surrounding regions — comparable as a Swedish life science-focused incubator with academic ties, though operating in a different Swedish region.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/KIInnovationsAB
• LinkedInlinkedin.com/company/karolinska-innovations-ab
• Instagraminstagram.com/kisciencepark

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KI Innovations AB